Establishment Labs Holdings (ESTA) Profit After Tax Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.30% |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | 35.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.38% |
| Dec 31, 2025 | 92.43% |
| Sep 30, 2025 | 33.19% |
| Jun 30, 2025 | 3.42% |
| Mar 31, 2025 | -27.82% |
| Dec 31, 2024 | -68.10% |
| Sep 30, 2024 | 43.01% |
| Jun 30, 2024 | -2.60% |
| Mar 31, 2024 | -35.67% |
| Dec 31, 2023 | -51.47% |
| Sep 30, 2023 | -57.31% |
| Jun 30, 2023 | 54.87% |
| Mar 31, 2023 | -101.28% |
| Dec 31, 2022 | 4.43% |
| Sep 30, 2022 | -26.77% |
| Jun 30, 2022 | -597.22% |
| Mar 31, 2022 | 14.61% |
| Dec 31, 2021 | -151.12% |
| Sep 30, 2021 | -245.77% |
| Jun 30, 2021 | 49.18% |
| Mar 31, 2021 | 60.86% |
| Dec 31, 2020 | -1.71% |
| Sep 30, 2020 | 66.77% |
| Jun 30, 2020 | -15.84% |
| Mar 31, 2020 | -64.70% |
| Dec 31, 2019 | 47.16% |
| Sep 30, 2019 | -1,078.18% |
| Jun 30, 2019 | -68.66% |
| Mar 31, 2019 | -65.07% |
| Dec 31, 2018 | -47.40% |
| Sep 30, 2018 | 112.24% |
| Jun 30, 2018 | 55.67% |